Molecular and cellular basis of interleukin 12 activity in prophylaxis and therapy against infectious diseases

Trinchieri, 1995, Interleukin-12: a pro-inflammatory cytokine with immunoregulatory functions that bridge inmate resistance and antigen-specific adaptative immunity, Ann. Rev. Immunol., 13, 252, 10.1146/annurev.iy.13.040195.001343 Trinchieri, 1995, 62nd Forum in Immunology: immunoregulation by interleukin-12, Res. Immunol., 146, 419 Biron, 1995, Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome, Curr. Opin. Immunol., 7, 485, 10.1016/0952-7915(95)80093-X Kobayashi, 1989, Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes, J. Exp. Med., 170, 827, 10.1084/jem.170.3.827 Wolf, 1991, Cloning of cDNA for natural killer stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells, J. Immunol., 146, 3074, 10.4049/jimmunol.146.9.3074 D'Andrea, 1992, Production of natural killer cell stimulatory factor (NKSF/IL-12) by peripheral blood mononuclear cells, J. Exp. Med., 176, 1387, 10.1084/jem.176.5.1387 Gazzinelli, 1993, Interleukin 12 is required for the T-lymphocyte independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts, 90, 6115 Chehimi, 1994, Impaired interleukin 12 production in human immunodeficiency virus-infected patients, J. Exp. Med., 179, 1361, 10.1084/jem.179.4.1361 Reiner, 1994, Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection, J. Exp. Med., 179, 447, 10.1084/jem.179.2.447 Carrera, 1996, Leishmania promastigotes selectively inhibit IL-12 induction in bone-marrow derived macrophages from susceptible and resistant mice, J. Exp. Med., 183, 515, 10.1084/jem.183.2.515 Grunvald, E. ket al. Biochemical characterization and protein kinase C dependency of monokine inducing activities in Toxoplasma gondii, Infect. Immun. (in press) Yoshida, 1994, IFN-γ induces IL-12 mRNA expression by a murine macrophage cell line, J774, Biochem. Biophys. Res. Commun., 198, 857, 10.1006/bbrc.1994.1122 Ma, 1996, The interleukin 12 p40 gene promoter is primed by IFN-γ in monocytic cells, J. Exp. Med., 183, 147, 10.1084/jem.183.1.147 Tripp, 1994, Neutralization of IL-12 decreases resistance to Listeria in SCID and CB-17 mice, reversal by IFN-γ, J. Immunol., 152, 1883, 10.4049/jimmunol.152.4.1883 Gazzinelli, 1994, Parasite induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii, J. Immunol., 153, 2533, 10.4049/jimmunol.153.6.2533 Seder, 1993, IL-12 acts directly on CD4+ T cells to enhance priming for IFN-γ and diminishes IL-4 inhibition of such priming, 90, 10188 Tripp, 1995, Secondary response to Listeria infection requires IFN-γ but is partially independent of IL-12, J. Immunol., 155, 3427, 10.4049/jimmunol.155.7.3427 Clerici, 1993, Restoration of HIV-specific cell-mediated immune responses by interleukin 12 in vitro, Science, 262, 1721, 10.1126/science.7903123 Gazzinelli, 1994, In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS), J. Exp. Med., 180, 2199, 10.1084/jem.180.6.2199 Orange, 1994, Effects of IL-12 on the response and susceptibility to experimental viral infections, J. Immunol., 152, 1253, 10.4049/jimmunol.152.3.1253 Virgil, 1995, IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-γ-receptor deficient mice, J. Immunol., 155, 2525, 10.4049/jimmunol.155.5.2525 Bi, 1995, IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system, J. Immunol., 155, 5684, 10.4049/jimmunol.155.12.5684 Bohn, 1996, IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-γ production in NK cells and CD4+ T cells, J. Immunol., 156, 1458, 10.4049/jimmunol.156.4.1458 Flynn, 1995, IL-12 increases resistance of BALB/c mice to Myobacterium tuberculosis infection, J. Immunol., 155, 2515, 10.4049/jimmunol.155.5.2515 Sieling, 1994, IL-12 regulates T helper 1 cytokine responses in human infectious disease, J. Immunol., 153, 3639, 10.4049/jimmunol.153.8.3639 Wyzocka, 1995, Interleukin 12 is required for IFN-γ production and lethality in lipopolysaccharide-induced shock in mice, Eur. J. Immunol., 25, 672, 10.1002/eji.1830250307 Romani, 1994, IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis, J. Immunol., 153, 5167, 10.4049/jimmunol.153.11.5167 Zhou, 1995, IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ, J. Immunol., 155, 785, 10.4049/jimmunol.155.2.785 Clemons, 1994, Cytokine treatment of central nervous system infection: efficacy of IL-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis, Antimicrob. Agents Chemother., 38, 460, 10.1128/AAC.38.3.460 Sypeck, 1993, Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective type 1 immune response, J. Exp. Med., 177, 1797, 10.1084/jem.177.6.1797 Heinzel, 1993, Recombinant interleukin 12 cures mice infected with Leishmania major, J. Exp. Med., 177, 1505, 10.1084/jem.177.5.1505 Afonso, 1994, The adjuvant effect of interleukin 12 in a vaccine against Leishmania major, Science, 263, 235, 10.1126/science.7904381 Nabora, 1995, A switch from a Th2 to Th1 type response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and pentostam, 92, 3142 Murray, 1995, Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis, J. Exp. Med., 181, 387, 10.1084/jem.181.1.387 Stevenson, 1995, IL-12-induced protection against blood-stage Plasmodium chaubaudi requires IFN-γ and TNF-α and occurs via nitric oxide-dependent mechanism, J. Immunol., 155, 2545, 10.4049/jimmunol.155.5.2545 Sedegah, 1994, Interleukin 12: induction of IFN-γ dependent protection against malaria, 91, 10700 Urban, 1996, IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum, J. Immunol., 156, 263, 10.4049/jimmunol.156.1.263 Aliberti, 1995, IL-12 mediates resistance to Trypanosoma cruzi infection in susceptible mice and is produced by normal murine macrophages cultured with live trypomastigotes, Mem. Inst. Oswaldo Cruz, 90, 172 Wynn, 1995, An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection, Nature, 376, 594, 10.1038/376594a0 Gately, 1994, Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo, Int. Immunol., 6, 157, 10.1093/intimm/6.1.157 Fauci, 1993, Multifactorial nature of human immunodeficiency virus disease: implications for therapy, Science, 262, 1011, 10.1126/science.8235617